MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

Search

Globus Medical Inc (Class A)

Chiusa

SettoreSettore sanitario

90.26 -1.58

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

88.46

Massimo

91.68

Metriche Chiave

By Trading Economics

Entrata

-84M

119M

Vendite

24M

769M

P/E

Media del settore

30.573

90.831

EPS

1.18

Margine di Profitto

15.469

Dipendenti

5,300

EBITDA

22M

215M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+10.02% upside

Dividendi

By Dow Jones

Utili prossimi

19 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

4.1B

12B

Apertura precedente

91.84

Chiusura precedente

90.26

Notizie sul Sentiment di mercato

By Acuity

25%

75%

63 / 361 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Globus Medical Inc (Class A) Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 gen 2026, 19:05 UTC

I principali Market Mover

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13 gen 2026, 23:41 UTC

Discorsi di Mercato

Nikkei May Rise on Japan Election Hopes -- Market Talk

13 gen 2026, 23:41 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

13 gen 2026, 23:33 UTC

Discorsi di Mercato

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13 gen 2026, 23:13 UTC

Acquisizioni, Fusioni, Takeovers

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13 gen 2026, 23:10 UTC

Acquisizioni, Fusioni, Takeovers

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13 gen 2026, 23:03 UTC

Discorsi di Mercato

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13 gen 2026, 21:50 UTC

Acquisizioni, Fusioni, Takeovers

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13 gen 2026, 21:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Basic Materials Roundup: Market Talk

13 gen 2026, 21:20 UTC

Acquisizioni, Fusioni, Takeovers

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13 gen 2026, 21:20 UTC

Acquisizioni, Fusioni, Takeovers

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13 gen 2026, 21:20 UTC

Acquisizioni, Fusioni, Takeovers

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13 gen 2026, 21:15 UTC

Acquisizioni, Fusioni, Takeovers

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13 gen 2026, 21:08 UTC

Acquisizioni, Fusioni, Takeovers

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13 gen 2026, 20:39 UTC

Discorsi di Mercato

Silver Settles at Another New High -- Market Talk

13 gen 2026, 20:21 UTC

Discorsi di Mercato

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13 gen 2026, 20:17 UTC

Discorsi di Mercato

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13 gen 2026, 19:08 UTC

Acquisizioni, Fusioni, Takeovers

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13 gen 2026, 19:03 UTC

Utili

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13 gen 2026, 18:50 UTC

Utili

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13 gen 2026, 17:54 UTC

Discorsi di Mercato

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13 gen 2026, 17:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Global Equities Roundup: Market Talk

13 gen 2026, 17:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13 gen 2026, 17:49 UTC

Discorsi di Mercato

Analysts Call For Potential Record Ethanol Output -- Market Talk

13 gen 2026, 17:38 UTC

Discorsi di Mercato

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13 gen 2026, 17:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

13 gen 2026, 17:20 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

13 gen 2026, 17:20 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Basic Materials Roundup: Market Talk

13 gen 2026, 17:19 UTC

Discorsi di Mercato

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13 gen 2026, 17:15 UTC

Discorsi di Mercato

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Confronto tra pari

Modifica del prezzo

Globus Medical Inc (Class A) Previsione

Obiettivo di Prezzo

By TipRanks

10.02% in crescita

Previsioni per 12 mesi

Media 104.1 USD  10.02%

Alto 118 USD

Basso 87 USD

Basato su 13 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Globus Medical Inc (Class A) - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

13 ratings

9

Acquista

4

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

72.18 / 73.07Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Weak Bearish Evidence

Sentiment

By Acuity

63 / 361 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat